Skip to main content
. 2023 Nov 4;15(21):5288. doi: 10.3390/cancers15215288
CESM Contrast Enhanced Spectral Mammography
NACT Neoadjuvant Chemotherapy
NAT Neoadjuvant Therapy
pCR pathological complete response
pPR pathological partial response
ML Machine Learning
DL Deep Learning
AUC Area Under Curve (ROC)
SEN Sensitivity
SPE Specifecity
HER-2 Human Epidermal Growth Factor Receptor-2
ER Estrogen Receptor
PR Progesterone Receptor
BPE Background Parenchymal Enhancement
DCE-MRI dynamic contrast-enhanced magnetic resonance imaging
FGT Fibroglandular Tissue
TN Triple Negative
NGTDM Neighborhood Gray Tone Difference Matrix based features
GLCM Gray Level Co-occurrence Matrix
GLRLM Grey Level Run Length Matrix
GLSZM Grey Level Size Zone Matrix